Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Puma Biotechnology, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 104 | 2 | 89 | −13 |
| Shares | 29.9M | 397.6K | 27.9M | −1.64M (−5.6%) |
| Value | $86.1M | $1.15M | $79.5M | −$5.45M (−6.4%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,500,000 | $4.28M | 0.07% |
| Ergoteles LLC | 143,100 | $408.0K | 0.01% |
| Bailard, Inc. | 53,500 | $152.0K | 0.01% |
| Atria Wealth Solutions, Inc. | 35,200 | $100.0K | 0.00% |
| Qube Research & Technologies Ltd | 29,310 | $84.0K | 0.00% |
| Buckingham Strategic Partners | 19,220 | $55.0K | 0.00% |
| HRT Financial LP | 18,035 | $51.0K | 0.00% |
| Two Sigma Securities, LLC | 14,156 | $40.0K | 0.01% |
| LMR Partners LLP | 11,514 | $33.0K | 0.00% |
| Jane Street Group, LLC | 11,076 | $32.0K | 0.00% |
| Gladius Capital Management LP | 9,811 | $28.0K | 0.01% |
| Eagle Bay Advisors LLC | 6,500 | $18.5K | 0.01% |
| Leonteq Securities AG | 5,000 | $14.3K | 0.00% |
| Simplex Trading, LLC | 3,463 | $9.00K | 0.00% |
| Crewe Advisors LLC | 579 | $2.00K | 0.00% |
| Credit Suisse AG | 17 | $0 | 0.00% |
| Ellevest, Inc. | 94 | $0 | 0.00% |
Sold out (30)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 392,321 | $1.13M |
| Amalgamated Financial Corp. | 5,256 | $15.0K |